DKK1 and Alzheimer disease: Indeed, the treatment of hippocampal slices with antibodies against the Wnt inhibitor DKK1 reverts the adverse effects observed in AD brains (De Ferrari et al., 2003; Alvarez et al., 2004; Cerpa et al., 2010; Purro et al., 2012).